Atsena Therapeutics’ founder and chief scientific officer discusses her role as CSO, the latest developments with ATSN-101, trends in the ocular gene therapy space, and more.
The opening session of Optometry’s Meeting 2025 included the launch of an initiative to get pediatric patients the care they need and a look at the condition of the profession
In pursuing his lifelong passion for athletics, Collin Liberty has never let anything stand in his way. A soccer enthusiast from childhood, Liberty was determined to play the sport in college and then launch a professional soccer career.
Cedars-Sinai Pulse
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
The Turro Lab is uncovering the genetic roots of rare and undiagnosed diseases using advanced genome sequencing and statistical methods—offering long-sought answers to families and driving the discovery of new genetic syndromes that impact tens of thousands worldwide.
Eva Morava, MD, PhD, and Tamas Kozicz, MD, PhD, are advancing therapies for rare metabolic disorders using organoid models and clinical trials—bringing personalized treatments to patients with congenital disorders of glycosylation and mitochondrial diseases.